COLO B Coloplast A/S Class B

Coloplast A/S - Announcement no. 12/2020 - Sustainability Report 2019/20

Coloplast A/S - Announcement no. 12/2020 - Sustainability Report 2019/20

The purpose of Coloplast inherently supports social development in society. By making life easier for people with intimate healthcare needs, we enable people to be active and take part in society. It is our priority to make sustainability easier for our users without compromising product safety and clinical performance. Our users do not choose their conditions and they should never be concerned about using Coloplast products in any way. Respect and responsibility are core values at Coloplast and Coloplast works continuously to improve and ensure responsible operations. Coloplast therefore has a solid foundation for working with sustainability.

As part of our corporate strategy, Strive25, we have assessed our impacts, and to advance sustainable development, Coloplast has set new priorities. While we have an on-going commitment to responsible operations, we will do even more to reduce our emissions as well as reducing the impacts from our products and packaging. As a company growing 7-9% annually, we are challenged with making absolute reductions of our emissions. Nonetheless, it is our ambition to use 100% renewable energy by 2025, and we will contribute to solving the problems associated with plastics. To deliver on our 2025 ambitions, we will invest up to DKK 250 million over the next five years.

Coloplast has reached its 2020 targets to increase share of renewable energy, recycle more of our waste and increase the diversity in our management. With these achievements, Coloplast has a solid foundation to do more.

Please find attached our Sustainability Report 2019/20 for more details.



For further information, please contact



Investors and analysts

Anders Lonning-Skovgaard

Executive Vice President, CFO

Tel.

Ellen Bjurgert

Vice President, Investor Relations

Tel. /

Email:

Press and media

Lina Danstrup

Sr. Media Relations Manager

Tel. 4911 2607

Email:

Address

Coloplast A/S

Holtedam 1

DK-3050 Humlebaek

Denmark

Company reg. (CVR) no. 69749917

Website

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2020-11.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachment

EN
03/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 Sep...

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025 The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.The purpose of the event is to give institutional investors and financial analysts an introductio...

Coloplast AS: 1 director

A director at Coloplast AS bought 18,450 shares at 650.500DKK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch